Search Results - Jiyong Liu

Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database by Wensheng Liu, Wensheng Liu, Qiong Du, Qiong Du, Zihan Guo, Zihan Guo, Xuan Ye, Xuan Ye, Jiyong Liu, Jiyong Liu

Connect to this object online.

CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug-gene interaction network by Youjun She, Youjun She, Zihan Guo, Zihan Guo, Qing Zhai, Qing Zhai, Jiyong Liu, Jiyong Liu, Qiong Du, Qiong Du, Zhongwei Zhang, Zhongwei Zhang

Connect to this object online.

Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study by Zihan Guo, Yunlan Ding, Mengmeng Wang, Qing Zhai, Jiyong Liu, Qiong Du

Connect to this object online.

Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles by Aixue Li, Yunan Zhao, Yixiu Li, Liangdi Jiang, Yongwei Gu, Jiyong Liu

Connect to this object online.

Plant-derived nanovesicles: Further exploration of biomedical function and application potential by Aixue Li, Dan Li, Yongwei Gu, Rongmei Liu, Xiaomeng Tang, Yunan Zhao, Fu Qi, Jifu Wei, Jiyong Liu

Connect to this object online.

Modification of sodium aescinate into a safer, more stable and effective water-soluble drug by liposome-encapsulation: an in vitro and in vivo study by Sifan Huang, Xinyu Wang, Mengmeng Liu, Zhizhe Lin, Wenqian Gu, Haili Zhao, Yanqiu Zhang, Baoyue Ding, Jiyong Liu, Xin Wu, Wei Fan, Jianming Chen

Connect to this object online.